Precision Medicine Market: Business Opportunities, Competitive Landscape And Forecast By 2025

Precision Medicine Market To Grow At 12.48% CAGR By 2025, according Global Precision Medicine Market 2020 Global Industry Forecast To 2025 Research Report published by Market Research Future.

Precision Medicine Market Overview: 

The report on a global scale regarding the precision medicine market would witness a rise by 12.48% CAGR during the forecast period encompassing 2019-2025 to reach and surpass a valuation by USD 126.14 billion. Market Research Future (MRFR) revealed that this growth would be substantial due to the inclusion of high throughput sequencing, increasing expenditure from several private companies and governments, development in the structure of the healthcare sector, better participation from pharmaceutical companies, growing rate of chronic diseases, and others. High chance of recovery would also trigger better precision medicine market expansion in the coming few years.  

Read more news on:

Precision Medicine Market Segmentation: 

The global market report on precision medicine can be segmented into ecosystem players, sub-markets, and therapeutics. This is to facilitate a proper study that would determine the growth of the global market in the coming years.  

By ecosystem players, the report on the global precision medicine market can be segmented into diagnostic companies, healthcare IT specialists/big data companies, pharmaceuticals and biotechnology companies, and clinical laboratories. The diagnostic tool companies segment has a substantial opportunity for growth from its previous valuation of USD 16.27 million in 2017. 

By sub-markets, the global report on the precision medicine market can be segmented into companion diagnostics, targeted therapeutics, biomarker-based tests, molecular diagnostics, pharmacogenomics (PGX), and others. 

By therapeutics, the global study containing the precision medicine market includes cardiovascular disease (CVD), cancer/oncology, infectious diseases, central nervous system, and others. 

Precision Medicine Market Regional Market: 

The market in America would lead the global scenario as it would be led by the US where the structure to support such researches are stronger than its peers. Along with it, the presence of Canada would boost the market outcome further. The regional market in the Northern part would see a constant flow of investment and a high inclusion rate of latest technologies. Better capacity to avail such methods would boost the market further. In the Southern region, this growth would be sluggish due to the presence of countries with poor infrastructure and investment capacity.  

In Europe, growth would be backed by government initiatives to bolster the research facilities and investments from pharmaceutical companies. The latter is a common trait for both North America and Europe. In Asia Pacific, these companies would launch extensive expansion plans in growing economies where the healthcare sector is witnessing a surge in activities.   

Precision Medicine Market Competitive Analysis: 

The global market report for precision medicine includes discussions regarding various types of strategic moves taken by top-players like Almac Group, Ltd., ABBOTT LABORATORIES, bioMérieux SA, ASURAGEN, INc., GlaxoSmithKline Plc (GSK), Cepheid Inc., CETICS Healthcare Technologies GmbH, GE Healthcare, Johnson & Johnson, Intomics A/S, Medtronic, Novartis, LABORATORY CORPORATION OF AMERICA HOLDINGS, Qiagen, Pfizer Inc, Randox Laboratories Ltd, BIOBASE GmbH (Subsidiary), Quest Diagnostics Inc., Sanofi Pharma, Takeda Pharmaceutical Company Limited, Roche Holding AG-Br, Caris Life Sciences, HealthCore, Inc., Teva Pharmaceutical Industries Ltd., Intel Corporation, Molecular Health GmbH, AB-Biotics SA, InnVentis, IBM, and Precision for Medicine. These players are known for their strategic moves like mergers, increasing investment in various research and development facilities, collaborations, and others.  

Obtain Premium Research Report Details @

Precision Medicine Industry News: 

In March 2020, researchers from Nemour’s Children’s Health System announced that they had identified a new type of variant in genetic structure that will help in manufacturing personalized drugs for patients with leukemia. Many researchers are looking at this as a possible counter-attack against the cancer. Researchers have suggested using next-generation sequencing that would increase precision in the detection of the process. 

Liquid Biopsy Market 2020 Global Industry Size, Analysis, Emerging Opportunities, Company Profile And Industry Segments Poised For Strong Growth In Future 2022

According to Liquid Biopsy Market 2020 Global Industry Analysis To 2022, report on “Global Liquid Biopsy Industry” published by Market Research Future, The Global Liquid Biopsy Market expected to rise at highest CAGR by 2022.

Liquid Biopsy Market Analysis  

The global liquid biopsy market is likely to touch USD 17,372.28 million at a whopping 28.0% CAGR between 2014- 2022, according to the new report by Market Research Future (MRFR). Liquid biopsy, simply put, is a minimally invasive test used to assess the cancer genetic status resting on the analysis of the circulating biomarker, which is present in the blood’s plasma component. Some of its wide applications include reproductive health, cancer, and others.  

Read more news on:

Various factors are adding to the global liquid biopsy market growth. According to the new MRFR report, such factors include growing awareness regarding the diagnosis of different types of cancer, multiple benefits of liquid biopsy such as less labor required, low cost, identification of specific mutations, and quick analysis, and extensive R&D in the diagnosis and treatment of cancer. Besides, the rising prevalence of cancer and burgeoning demand for non-invasive testing are also adding market growth.  

On the contrary, tumor heterogeneity being the biggest challenge in cancer research may limit the global liquid biopsy market growth over the forecast period. Besides, the production process in its entirety being adversely impacted due to the temporary shutdown of industries and complete lockdown following the COVID-19 pandemic that has limited the overall blood collection tubes for the global liquid biopsy market is also hindering the market growth. 

Liquid Biopsy Market Segmentation 

The MRFR report gives an inclusive segmental analysis of the global liquid biopsy market report based on end user, samples, application, and types. 

By types, the global liquid biopsy market is segmented into extracellular vesicles (EVS), circulating tumor DNA (CTDNA), circulating tumor cells (CTCS), and others. Of these, the circulating tumor cells segment will lead the market over the forecast period.  

By application, the global liquid biopsy market is segmented into reproductive health, cancer, and others.  

By sample, the global liquid biopsy market is segmented into forensic, urine sample, blood sample, and others. Of these, the blood sample segment will dominate the market over the forecast period.  

By end user, the liquid biopsy market is segmented into academic & research centers, hospitals and laboratories, and others. Of these, the hospitals and laboratories segment will have a major share in the market over the forecast period.  

Liquid Biopsy Market Regional Analysis 

Based on the region, the global liquid biopsy market report covers the growth opportunities and recent trends across North America, Europe, the Asia Pacific (APAC), & the Middle East and Africa (MEA). Of these, North America will spearhead the market over the forecast period. Improving healthcare infrastructure, increasing prevalence of cancer, and surging demand for non-invasive treatment is adding to the global liquid biopsy market growth in the region. The US has the maximum share in the region. 

The global liquid biopsy market in the APAC region is predicted to grow at a fast pace over the forecast period. The government’s focus on healthcare facilities, growing cancer cases, increased urbanization, and rising income are adding to the liquid biopsy market growth in the region.  

The global liquid biopsy market in Europe is predicted to hold the second-largest share over the forecast period. Rising geriatric population, growing prevalence of cancer, and a huge base of research & academic institutes & biopharmaceutical companies are adding to the liquid biopsy market growth in the region.  

The global liquid biopsy market in the MEA is predicted to have sound growth over the forecast period.  

Obtain Premium Research Report Details, Considering the impact of COVID-19 @ 

Liquid Biopsy Market Key Players 

Eminent players profiled in the global liquid biopsy market report include Exosome Diagnostics (Massachusetts), SAGA Diagnostics AB (Sweden), Inivata Ltd (UK), Circulogene Theranostics (Alabama), Biocept, Inc. KGaA (US), Admera Health (US), Agena Bioscience Inc. (California), RainDance Technologies, Inc. (US), Trovagene, Inc. (California),and Guardant Health, Inc. (US). 

Neuroendoscopy Market 2020: Business Strategies, Revenue, Opportunities, Challenges, Competitive Landscape And Gross Margin Analysis Till 2023

Neuroendoscopy Market 2020 Industry Research Report – Global Forecast to 2023, is latest research report on Global Neuroendoscopy Industry published by Market Research Future.

Neuroendoscopy Market Overview:

Neuroendoscopy is known as a minimally-invasive surgical technique that gives neurosurgeons an advantage in removing various tumors through a small hole in the skull. It can be used through mouth or nose as well. removes the tumor through small holes in the skull or through the mouth or nose. The technology provides a scope for various surgeries, which, otherwise, cannot be performed using traditional surgeries. The market for the neuroendoscopy is expecting high growth by 5.2% CAGR during the forecast period of 2017 to 2023. Market research Future (MRFR) makes an assessment of the market and in the report they declared the possibility of surpassing the market by 2023.

Read more news on:

Factors that can play crucial roles in taking the global market for neuroendoscopy forward are growing demand for minimally-invasive surgeries, surge in better technological integration in the market, and others. Apart from these, features like lessening of recovery time, integration of smart gadgets, and others can also improve the market scenario. 

Neuroendoscopy Market Segmentation:

The global Neuroendoscopy market, as discussed by MRFR in the study, spans across segments like product, application, usability, and end-user. These segments have details of various factors that can impact the global market in the coming years.

By products, the neuroendoscopy market would cover rigid neuroendoscopes and flexible neuroendoscopes. The rigid neuroendoscopes segment includes rigid video scopes and rigid fiberscopes. This sub-segmentation would provide advantages in dealing with the regular various details that can impact the market.

By application, the market for neuroendoscopy comprises intraventricular neuroendoscopy, transnasal neuroendoscopy, and transcranial neuro-endoscopy.

By usability, the segmentation of the neuroendoscopy market includes reusable neuroendoscopes and disposable neuroendoscopes.

By end-users, the neuroendoscopy market encompasses medical research centers, hospitals, clinics, and others.

Neuroendoscopy Market Regional Analysis:

The Americas has the better grip over the market as their technological superiority is going to allow them experience better growth. Several other factors are also expected to trigger better growth for the market. Better reimbursement policies, high investment for technologies, various tie-ups and other strategic moves, infrastructural advantage, and others can substantially impact the global market for neuroendoscopy.

Europe is following the lead of the Americas from a very close quarter. This growth receives much of the traction from countries like the UK, France, Germany, and others. The major reason behind this is the growing awareness regarding minimally invasive surgeries and availability of funding for various research and development teams.  

The APAC market has a lot to contribute as the revamping healthcare sector, inclusion of various technologies, and growing number of patients are impacting the market notably. Various government policies are also expected to provide traction to the market. In addition, the growth in the medical tourism is expected to take the market forward.

The Middle East and Africa market has the least market share as in the African region a lot of poor economies would hold back the market growth in the coming years. The Middle East, however, would express better possibilities owing to the presence of Dubai, Saudi Arabia, the UAE, Qatar, Kuwait, and others.

Neuroendoscopy Market Competitive Analysis:

Numerous companies are taking an active interest in the global neuroendoscopy market and they are solidifying their position in the market by constantly evolving their technologies. MRFR profiled a few in the report to get a feel of how the market is moving ahead and chalking out its future strategies. These companies are Ackermann Instrumente (Germany), Adeor Medical (Germany), KARL STORZ (Germany), B. Braun (Germany), Machida Endoscope (Japan), Hangzhou Hawk Optical Electronic Instruments (China), Tonglu Wanhe Medical Instrument (China), Clarus Medical (U.S.), Schindler Endoskopie (Germany), LocaMed (U.K), Medtronic (U.S.), Olympus Corporation (Japan), Zeiss International (Germany), Visionsense Corporation (U.S.), Stryker (U.S.), and others.

Obtain Premium Research Report Details @

In an article published in the Lancet in September 2019, researchers revealed a new way of preventing infection in patients who are expected to undergo neuroendoscopy treatments. The treatment would include antibiotics like rifampicin and clindamycin or silver shunts to reduce the cost of the procedure. It would deviate markedly from the standard procedures.

Dry Eye Syndrome Market: 2020 Global Industry Share, Size, Trends And Regional Forecast To 2023

Dry Eye Syndrome Market 2020 Global Industry Forecast to 2023 Research Report, is latest depth analysis report on Global Dry Eye Syndrome Market Size, Trends, Share, Growth, and Regional Analysis from 2018 to 2023.

Dry Eye Syndrome Market Overview:

Tears in eyes has a substantial role in lubricating the inner process and protecting eyes from infections or any other foreign matters. Dry eye syndrome is a disease where the lubrication process gets hindered due to lack of tear inflow. The global dry eye syndrome market is all ready to achieve 6.6% CAGR during the forecast period of 2017 to 2023. Market Research Future (MRFR) identified several growth opportunities that could trigger a positive effect.

Read more news on:

Geriatric population, diabetes, rheumatoid arthritis, are few of the diseases that can trigger dry eye syndrome. Better technological installations and treatment measures can also smoothen up the growth path for the dry eye syndrome market. However, stringent norms regarding medicine manufacturing can deter the market growth.

Dry Eye Syndrome Market Segmentation:

Type, diagnosis, treatment, distribution channel and end-user are segments in which the global dry eye syndrome market has been segmented by MRFR. This attempt would ensure better look into factors that can improve the market position.

Based on the type, the dry eye syndrome market comprises evaporative dry eye syndrome aqueous dry eye syndrome, and others.

Based on the diagnosis, the dry eye syndrome market comprises Schirmer test, eye exam, and others. The Schirmer test is gaining substantial acknowledgement.  

Based on the treatment, the dry eye syndrome market includes nutritional supplements, serum eye drops, lubricant eye drops, anti-inflammatory drugs segments, surgery, and others. The lubricant eye drops segment includes oily tear eye drops, ointments, preservative-free drops, and others. The anti-inflammatory drugs segment encompasses tetracyclines, corticosteroids, and others. The surgery segment has punctal occlusion, intense pulsed light therapy, and others under its purview.

Based on the distribution channel, the dry eye syndrome market consists online pharmacies, retail pharmacies, hospital pharmacies, and others. The retail pharmacies are doing good, however, the online pharmacies can gain more, if they clear stringent government policies.

Based on the end-users, the dry eye syndrome market includes hospitals, clinics, home care, and others.

Dry Eye Syndrome Market Regional Analysis:

The Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA) are segments that can be assessed to understand a proper functioning of the global dry eye syndrome market. This market segmentation includes a detailed study of various growth pockets, which can be taken into consideration to chart the progress route.

The Americas has significant market dominance and this is due to better diagnosis, infrastructural strength, high expenditure, and easy reimbursement policies. The presence of the US, and Canada are also expected to fetch in revenues. Cuba is also doing great in South America, along with Brazil and Argentina. The presence of several titans like Auven therapeutics, Johnson & Johnson Vision, Acadia Pharmaceutical, and others is also adding fuel to the market growth.

Europe has the second largest market and is getting benefitted from the high patient population. Healthcare sector in the region is quite robust and has a name for receiving remarkable funds from governments and private organizations. The APAC market is emerging as a market with high potential where India, China, Australia, and others are performing well. All these regions are expecting high CAGR during the forecast period.

Dry Eye Syndrome Market Competitive Landscape:

Various pharmaceuticals are impacting the global dry eye syndrome market by improving the competition in the market with strategic inclusions of processes like merger, acquisition, collaboration, and other methods. The global market is also gaining from such prolific moves. MRFR listed a few in their global dry eye syndrome market report and profiled them to get a hand over latest trends that could impact the market in the future. These companies are Novartis AG (Switzerland), Allergan (Republic of Ireland), Valent Pharmaceuticals (Canada), Otsuka Pharmaceutical Co. Ltd. (Japan), Acadia Pharmaceutical (U.S.), Johnson and Johnson Vision (U.S.), I-Med Pharma Inc. (Canada), Allostera Pharma (Canada), AFT pharmaceuticals (New Zealand), Santen Pharmaceuticals Co. Ltd., (Japan), Auven therapeutics (U.S.), Novaliq GmBh (Germany), and others.

Obtain Premium Research Report Details @

 In August 2019, results from phase 2 and 3 of the ribonucleic acid (siRNA) inhibitor tivanisiran delivered positive outcomes as a cure for dry eye syndrome. The test is getting done by researchers from Sylentis and it has been conducted in six countries. The result shows a stark improvement in the condition.

Cord Blood Banking Services Market 2020: Industry Overview, Driving Factors, Segments, Regional Analysis And Competitive Analysis – Forecast To 2023

Cord Blood Banking Services Market Research Report – Global Forecast till 2023, Published by Market Research Future. MRFR Provides Cord Blood Banking Services Industry Updates, Size, Share, Growth, Competitive Landscape, Regional Outlook

Cord Blood Banking Services Market Overview

According to Market Research Future (MRFR), the global market for cord blood banking services is projected to expand at 11.4% CAGR from 2017 to 2023 (forecast period).

Umbilical cord blood is an abundant source of stem cells capable of treating more than 80 genetic diseases. Stem cells can also combat long-lasting illnesses such as diabetes, cancer, immune diseases, and blood disorders. Although a small amount of cord blood can be obtained from a single umbilical cord, it contains a large number of stem cells that can be developed and stored for future use. After delivery, these cells are collected from hospitals and nursing homes and deposited in cord blood banks (average 20–25 years) for potential use. Now, companies are seeking to raise awareness of the benefits of cord blood storage. For example, in 2014, the Center for Transfusion Medicine and the Cord Blood Registry combined their resources to initiate a multi-year campaign to raise awareness of cord blood cells. 

Read more news on:

Cord Blood Banking Services Market Dynamics

Factors such as increasing the use of cord blood in the treatment of chronic diseases, raising the focus of federal agencies on setting up public banking units, raising awareness of this treatment line, and increasing number of facilities across the region are accelerating market growth.

However, strict regulatory standards, ethical concerns, and the dilemma of choosing private or public banks are vital factors that impede the growth of the market. In addition, the high cost of storage, collection, and risk of unusability of a private bank-stored unit further reduces the growth of the global market for cord blood banking services. 

Cord Blood Banking Services Market Segmentation

The global cord blood banking services market has been segmented based on storage service, component, application, and end-user.

Based on storage service, the global market for cord blood banking services has been segmented into hybrid cord blood banks, private cord blood banks, and public cord blood banks.

Based on components, the global market for cord blood banking services has been segmented into cord blood, cord tissue, placenta, and others.

Based on the application, the global market for cord blood banking services has been segmented into cancers, immune disorders, blood disorders, metabolic disorders, and osteoporosis.

Based on end-user, the global market for cord blood banking services has been segmented into hospitals (medical applications), research institutes (scientific research), pharmaceutical research (drug discovery), and others. 

Cord Blood Banking Services Market Regional Analysis

The global cord blood banking services market consists of four regions: the Americas, Europe, Asia Pacific, and the Middle East and Africa.

The Americas region held the largest market share of the global market for cord blood banking services due to the increasing number of service providers, increasing awareness of the long-term benefits of cord blood storage, increasing investment in public banking, and reduction in storage costs. In addition, the U.S. is contributing to a significant market share for the global cord blood banking industry. Factors include a rise in per capita income, an increase in the number of storage service providers, and a high acceptance rate for new technology attributed to the largest market share.

The European cord blood banking market is the second-largest market, followed by the Asia Pacific region. 

The Asia Pacific region is projected to dominate the global market for cord blood banking services in terms of growth in the forecast period. Although the region currently has a small share of the global market, it is projected to have enormous growth potential as a result of increasing awareness of stem cell banking and significant improvements in health care reforms in countries such as Malaysia, India, Indonesia, and China. Moreover, Asia Pacific is a mostly unexplored regional market compared to developed regions, which is why it provides better opportunities for business growth.

The Middle East region is anticipated to expand at a steady pace due to growing R&D activities in the healthcare sector and the overall growth of healthcare infrastructure. 

Cord Blood Banking Services Market Key Players

Some of the leading participants in the global cord blood banking services market are Cordlife Group Limited (Singapore), China Cord Blood Corporation (China), Cord Blood America, Inc. (U.S.), Cryo-Cell International, Inc. (U.S.), CBR Systems, Inc. (U.S.), Cryo-Save AG (Netherland), Lifeforce Cryobank Sciences Inc. (U.S.), California Cryobank Stem Cell Services LLC (U.S.), Virgin Health Bank (Qatar), StemCyte, Inc. (India), ViaCord, Inc. (U.S.), Norton Healthcare, Inc. (U.S.), CordVida (Brazil), CryoHoldco de Latinoamerica, S.A.P.I. De C.V. (Mexico), The University of Colorado Cord Blood Bank (U.S.), Vita 34 International (Germany), Maze Cord Blood Laboratories (U.S.), Lifebank USA (U.S.), Cryoviva Biotech Pvt. Ltd (India), CariCord (U.S.), Genecord (U.S.), AlphaCord (U.S.), Cells4Life (UK), Carter BloodCare (U.S.), Michigan Blood (U.S.), Viacord Processing Laboratory (VPL) (U.S.), LifeCell International Pvt. Ltd (India), FamilyCord (U.S.), Stem Cell Cryobank Inc. (U.S.), New Jersey Cord Blood Bank (U.S.), Americord Registry (U.S.), CorCell (U.S.), and others.

Obtain Premium Research Report Details, Considering the impact of COVID-19 @ 

Immunofluorescence Assay Market Opportunities, Challenges, Competitive Landscape, Gross Margin Analysis, Competitors Strategies, Revenue, Gross Margin Research Report And Trends By Forecast 2023

“The Latest Research Report Global Immunofluorescence Assay Market By 2023 provides information on Market Size, Analysis, Shares, Forecast, Emerging Technologies and Company Profiles for key Industry Participants – Market Research future”

Immunofluorescence Assay Market Overview

The global immunofluorescence assay market is growing pervasively. The market growth attributes to the increase in biological studies in R&D for the detection of biomolecules like glycans, proteins, and small biological and non-biological molecules of various diseases. Also, immunofluorescence assays are primarily used for rapid and sensitive diagnostics of various chronic diseases such as cancer, autoimmune diseases, infectious diseases like HIV, neurological disorders such as Alzheimer’s and Parkinson’s diseases.

With the intervention of the COVID-19, the immunofluorescence assay industry is witnessing a massive demand across the globe. This is due to the rising usages of immunofluorescence assays in the development of antibodies that can detect sars-Cov-2 in patient samples. According to Market Research Future (MRFR), the global immunofluorescence assay market is projected to register 5.8% CAGR during the analysis period (2017–2023).

Read more news on:

Advancements in medical technology, alongside the increasing R&D funding by industry leaders and governments, boost the market growth. Additionally, rising numbers of preclinical research, alongside the rising studies on antibody therapies, advanced drug discoveries, and oncology diseases, accelerate the market growth. Growing collaborations between research institutes and biotechnology companies are expected to drive the growth of the immunofluorescence assay market.

Conversely, the high cost of immunofluorescence assay products such as diagnostic kits is expected to restrict the market growth during the forecast period. Also, factors such as risks of cross contaminations and shortage of skilled labor & weak detection signals are estimated to impede the growth of this market.  Nevertheless, growing advancements in biotechnology & medical science would support the growth of the market, bringing about cost-effective immunofluorescence assay.  

Global Immunofluorescence Assay Market – Segmentation

The Immunofluorescence Assay Marketreport is segmented into five dynamics;  

By Technique: Primary (Direct) Immunofluorescence Assays and Secondary (Indirect) Immunofluorescence Assays (Salt split technique, Antigenic mapping method, Double Staining method), Micro Immunofluorescence.

By Product Type: Antibodies, Kits & Reagents, Instruments, Microscopes, Imaging Analysis Systems, Labeling dyes, Species Product Type, and others.

By Application: Clinical Research, Clinical Diagnostics, Infectious Diseases, Cancer, Cardiovascular Diseases, Autoimmune Diseases, Neurological Diseases, Research & Development, and others.

By End-User: Biotechnology Companies, Hospitals & Research Institutes, Contract Research Organizations, Diagnostic centers, and others.

By Regions:  Americas, Europe, Asia Pacific, and Rest-of-the-World. 

Global Immunofluorescence Assay Market – Regional Analysis

North America dominates the global immunofluorescence assay market. The largest market share attributes to the high prevalence of chronic diseases and rising R&D investments within this region. Also, the rising adoption of advanced systems for early diagnosis of diseases drives the regional market growth. Moreover, the advancement in the development techniques and increasing use of nanotechnology in the development of immunofluorescence assay fostered the growth of the regional market.

The US, among other North American countries, holds the largest share in the regional market. Besides, the presence of vast numbers of biotechnology & pharmaceutical companies impacts the regional market growth positively. The North American immunofluorescence assay market is estimated to retain its leading position throughout the assessment period.

Europe stands second in the immunofluorescence assay market. The market is driven by the increasing prevalence of myriads of chronic diseases such as cancer and the rapidly growing biotechnology sector in Europe. Moreover, substantial R&D investments by the public and private sectors, alongside the increasing R & D in biotechnology, foster the market growth in the region. The European immunofluorescence assay market is projected to create a substantial revenue pocket over the review period.

The immunofluorescence assay market in the Asia Pacific region is growing rapidly. Factors such as the growing patient pool, high incidence of chronic diseases, developing healthcare infrastructure, and increasing R&D activities in the biotechnology sector influence the market in this region. Also, the presence of major market players in China, India, and Japan drive market growth. Rising government initiatives increase the size of the immunofluorescence assay market in the region.

The region witnesses rising developments of immunofluorescence assay products, while several products are under the pipeline, which is carried out under license agreements. The APAC immunofluorescence assay market is expected to grow at an impressive CAGR during the predicted period. 

Global Immunofluorescence Assay Market – Competitive Analysis

Highly competitive, the global immunofluorescence assay market appears fragmented due to the presence of several well-established players. To gain a larger competitive advantage, players incorporate strategies such as mergers & acquisitions, collaborations, expansion, and product/technology launch. Top players make huge investments for R&D and clinical trials to develop these assays. Pharmaceutical companies are the largest investors in the immunofluorescence assay market. 

Immunofluorescence Assay Market Major Players: 

Players leading the global immunofluorescence assay market include Abcam plc., Thermo Fisher Scientific, BioLegend, Inc., Enzo Life Sciences, Inc., Sino Biological Inc., BioTek Instruments, Inc., Bio-Rad Laboratories, Inc., Zyagen Cell Signaling Technology, Inc., PerkinElmer Inc., Becton Dickinson and Company, Merck, Agilent Technologies, TCS Biosciences Ltd, and Maxvision Biosciences Inc., among others. 

Immunofluorescence Assay Industry/Innovation/ Related News:

May 29, 2020 — Rockland Immunochemicals Inc. (the US), a leading global biotechnology company, announced the development of a critical antibody reagent essential to antibody tests used to determine SARS-CoV-2 exposure for patients suspected to have contracted COVID-19. The antibody specifically reacts with the SARS-CoV-2 Nucleocapsid protein present in patient samples and has shown in various independent testing laboratories in regions highly specific and sensitive for SARS-CoV-2.

Rockland manufactures tools for basic, applied, and clinical research in functional genomics, gene therapy, and drug discovery markets. It offers each academic, biopharma, and professional diagnostic thousands of antibodies to provide the right antibody that is the perfect fit for every occasion. The newly developed antibody has proven effective in lateral flow assays (immunochromatography), ELISA, Western blotting, Immunofluorescence microscopy, fluorescence-activated cell sorting, and immunohistochemistry.

Obtain Premium Research Report Details, Considering the impact of COVID-19 @

Breastfeeding Accessories Market 2020 Leading Growth Drivers, Emerging Audience, Emerging Factors, Segments, Sales, Profits & Analysis

Market Research Future (MRFR) has Thoroughly Studied the Trends and Patterns in the Global Breastfeeding Accessories Market. The Report offers insights into the Leading Market Players and Presents an Assessment of their Current Market Position.

Breastfeeding Accessories Market Analysis 

The global breastfeeding accessories market size is projected to grow at a 7.8% CAGR between 2018-2024, reveals the new Market Research Future’s breastfeeding accessories market report. Breastfeeding accessories comprise of a long list of items such as breast shells, cleaning products, nipple care products, nursing pads, breastfeeding pillow, nursing clothes, breast pumps, breast milk bottles, and others that help to make breastfeeding simpler. These essential supplies, along with helping the mother to remain in the flow, will also at the same time keep her and her baby comfortable and happy.  

Read more news on:

Numerous factors are adding to theglobal breastfeeding accessories or breastfeeding device market growth. Such factors, according to the recent MRFR report, include favorable breastfeeding promoting policies, improving healthcare infrastructure, decrease in infant mortality rate, rise in female employment rate, and increasing awareness about these accessories.  

On the contrary, the high price of products may limit the global breastfeeding accessories market growth over the forecast period. 

Breastfeeding Accessories Market Segmentation 

The Market Research Future Report provides an inclusive segmental analysis of the global breastfeeding accessories market based on end user and product.  

By product, the breastfeeding accessories market is segmented into breast shells, cleaning products, nipple care products, nursing pads, breastfeeding pillow, nursing clothes, breast pumps, breast milk bottles, and others. Breast pumps are again segmented into electric and manual breast pumps. Nursing pads are again segmented into reusable and disposables. Breast shell is a vital breastfeeding product for women having leaky breasts, sore nipples, or inverted nipples. Breast cleaning products are used to clean the breast after feeding. Nipple care products are available in different types to provide care to cracked/sore nipples. Nursing pads help in absorbing the surplus milk, thereby protecting the mother’s clothing from stains and wetness. Breastfeeding pillow helps the mother to hold the little one in different positions, thus making it comfortable for both. Besides breastfeeding, these pillows can also be used to offer some soft cushioning, assist with tummy time, and prop babies up. Nursing clothes are designed for the mother’s comfort both at the time of pregnancy and after. A breast pump helps in emulating a nursing baby via mimicking the natural suckling pattern. A breast milk bottle is immensely handy as it helps to collect, store, and feed breast milk. 

By end user, the breastfeeding accessories market is segmented into personal and hospital & clinics.  

Breastfeeding Accessories Market Regional Analysis

By region, the global breastfeeding accessories market covers the growth opportunities and recent trends across Europe, the Americas, the Middle East & Africa (MEA), and the Asia Pacific (APAC). Of these, the Americas will have the lions share in the market over the forecast period. Factors adding to the breastfeeding accessories market growth in the region include favorable breastfeeding promotion policies, demand for innovative breastfeeding accessories, and developing healthcare infrastructure. Besides, the presence of several milk banks and growing awareness about these accessories are also adding market growth.  

The breastfeeding accessories market in Europe is predicted to hold the second-largest share over the forecast period. Factors adding to the breastfeeding accessories market growth in the region include the increasing number of milk banks and hospitals for children, increasing support from the government to improve children’s health, and rising woman employment.  

The breastfeeding accessories market in the APAC region will grow at a quick pace over the forecast period for increasing birth rate that automatically boosts the need for such accessories, increasing healthcare expenditure by the government, and presence of several developing economies in the region such as India, Australia, and China.  

The breastfeeding accessories market in the MEA will have a small share over the forecast period for lack of healthcare infrastructure, low awareness, and poor economies.  

Breastfeeding Accessories Market Key Players 

Notable players profiled in the breastfeeding accessories market report include Tommee Tippee/Mayborn Group Limited (UK), NNUK USA LLC (US), Medline Industries, Inc. (US), Handi-Craft Company (US), Artsana S.p.A. (UK), Nuby (USA), Pigeon Corporation (Japan), Ameda (US), Medela LLC (US), and Koninklijke Philips N.V. (UK). 

Obtain Premium Research Report Details @ 

Breastfeeding Accessories Industry News 

February 2020: The Wing and Medela have joined hands to assist co-working females in attaining their breast milk feeding goals.

Automatic Pill Dispenser Market Application, Solutions, Developments Status, Innovative Technologies, Segmentation, Trends And Business Opportunities 2020-2024

MRFR is the Leading Brand in The Research Company Who Recently Published Global Automatic Pill Dispenser Market Research Reports which includes Market Size, growth, Regional Analysis, Top Industry Players Formation, Major Drivers, Trends and Forecast to 2023

Automatic Pill Dispenser Market Highlights

Market Research Future (MRFR) analysed the Global Automatic Pill Dispenser Market 2020 till 2024. As per MRFR findings, the worldwide automatic pill dispenser market can rise at 7.3% CAGR in the review period. By 2024, the automatic pill dispenser market value can exceed USD 1,700 Mn. The growing preference for automatic pill dispenser among a prevalent geriatric populace due to its high patient convenience can boost the rise of the market. Increase in chronic ailment cases, following acute clinical condition, is creating the need for advanced and seamless drug administration solutions. 

Read more news on:

This is boosting the sales of automatic pill dispense that can provide thrust to the market. Tablets and capsules are common dosage form prescribed to patients over liquid form of any drugs. Thus, the term of service offered by automatic pill dispensers is high. This can improve the impetus of the market in the years ahead.  Upgradation in automatic pill dispenser design, untapped emerging markets, rise in number of home care centers, and rise in regulatory approvals are other causes that can propel the rise of the market. On the contrary, the expensiveness of the system can limit the growth of the automatic pill dispenser market through the evaluation period.

Automatic Pill Dispenser Market Segmentation 

The segment assessment of the automatic pill dispenser market is done by end user, and type.

The type based segment of the automatic pill dispenser market are automated dispensing system, centralized, and decentralized the automated dispensing system. The segment of centralized automated dispensing system sub-segments are carousels and robotic automated dispensing systems. The sub-segments of the decentralized automated dispensing system are ward-based automated dispensing system, pharmacy-based automated dispensing system, and automated unit dose dispensing system. The automated dispensing system is observed to hold high traction. 

The end user-based segments of the automatic pill dispenser market are retail pharmacy, hospital pharmacy, and home healthcare. The centralized automated dispensing system segment can thrive in the upcoming years. The growing adoption of automatic pill dispenser in hospitals and other healthcare facilities can support the expansion of the market across the analysis period. 

Automatic Pill Dispenser Market Regional Analysis 

Regional trends and factors for the automatic pill dispenser market is done for the Americas, EU, APAC, and the Middle East and Africa.

In America, the automatic pill dispenser market can surge owing to the increased demand for effective drug administration solutions. The expansion of the market in Americas can also be attributed to the increase in the number of marketers dealing in automatic pill dispenser. In addition, the robust economic support of the region can also bolster the regional market rise. Europe automatic pill dispenser market can thrive due to rise in the prevalence of numerous chronic ailments, such as cardiovascular disorders and hyperthyroidism among others. The automatic pill dispenser market in Europe can touch a decent valuation due to the existence of advanced medical technologies and the availability of several funding opportunities. In APAC, the growing geriatric populace, a high end-consumer of automatic pill dispenser market, can promote the regional market rise. In Middle East and Africa, the automatic pill dispenser market can witness a steady expansion as the economic development in the region is slow.

Automatic Pill Dispenser Market Key Players

Becton, Talyst, Inc., Cerner Corporation, McKesson Corporation, Capsa Healthcare, ScriptPro LLC, Omnicell Inc., Swisslog Holdings AG, Baxter International Inc, Dickinson and Company, and Yuyama Co.Ltd among others are some reputed players that operating in the automatic pill dispenser market listed by MRFR.

Obtain Premium Research Report Details, Considering the impact of COVID-19 @

Mortuary Equipment Market Trends, Sales, Supply, Demand, Analysis, Share, Comprehensive Research Study, Emerging Technologies And Potential Of Industry From 2019-2024

Market Research Future published a Cooked research report on “Global Mortuary Equipment Market Research Report, forecast to 2024” – Market Size, Share, Growth, Analysis, Regional Outlook, Scope, Stake, Progress, Trends.

Mortuary Equipment Market Overview

The global mortuary equipment market is expected to exhibit a robust 6.48% CAGR over the forecast period from 2019 to 2024, according to the latest research report from Market Research Future (MRFR). The global mortuary equipment market is expected to reach a valuation of close to USD 1.3 billion by 2024. The report presents a detailed analysis of the global mortuary equipment market, providing readers with a complete overview of the market’s major drivers and restraints. Leading players operating in the global mortuary equipment market are also profiled in the report to give readers a clear overview of the market’s competitive landscape.

Read more news on:

The mortuary equipment market is mainly driven by the growing demand for technological updation and automation in mortuaries. Due to the unpleasant nature of the work involved in mortuaries, many mortuaries are opting for automated machines that can carry out the work of multiple human workers easily and with no fuss. Mortuary equipment developers have consequently come up with several new technological upgrades to make the job of mortuary technicians easier and more agreeable. The increasing demand for technological upgrades make mortuary work easier and more palatable is likely to be a major driver for the global mortuary equipment market over the forecast period.

Mortuary equipment is a growing market in Asia Pacific, where awareness regarding mortuaries is relatively low. This is likely to be a major driver for the mortuary equipment market over the forecast period, as there is significant unmet potential in the market. Growing awareness about mortuaries and the increasing state expenditure to make mortuaries more technologically updated and modern are likely to be major drivers for the global mortuary equipment market over the forecast period.

Mortuary Equipment Market Competitive Analysis:

Leading players in the global mortuary equipment market include Flexmort, Funeralia GmbH, EIHF Isofroid, Barber of Sheffield, Ferno-Washington Inc., Mopec Inc., Mortech Manufacturing Company Inc., HYGECO, Thermo Fisher Scientific, SM Scientific Instruments Pvt. Ltd., KUGEL Medical GmbH & Co. KG, and LEEC Limited.

Mortuary Equipment Market Segmentation:

The global mortuary equipment market is segmented by product type, end use, and region.

By product type, the global mortuary equipment market is segmented into refrigeration units, embalming workstations, dissection tables, autopsy platforms, cadaver lifts and trolleys, and others. The refrigeration units segment accounted for the largest share of USD 231.4 million in 2018 and is likely to remain the leading revenue generator over the forecast period.

By end use, the global mortuary equipment market is segmented into hospitals, academic institutes and research organizations, forensic laboratories, and others.

Mortuary Equipment Market Regional Analysis:

The Americas is likely to remain the leading revenue generator in the global mortuary equipment market over the forecast period, followed by Europe and Asia Pacific. Widespread awareness about mortuary technology and equipment and the growing government assistance to the healthcare sector are likely to be the major drivers for the mortuary equipment market in the Americas over the forecast period. The growing geriatric population is also likely to drive the mortuary equipment market in the Americas, as the death rate is likely to rise in the coming years.

Asia Pacific is likely to be an important regional market for mortuary equipment, due to the massive unmet demand in regions such as China and South Korea. Japan, China, South Korea, India, and Australia are the leading regional markets within the Asia Pacific mortuary equipment market and are likely to represent the strongest growth prospects over the forecast period due to the growing scope for the growth of the healthcare sector in the region. Increasing awareness about mortuaries has also led to a growing demand for mortuary equipment in Asia Pacific and is likely to remain a key driver over the forecast period.

The Middle East and Africa is also likely to be a key market for the global mortuary equipment market due to the growing demand in leading economies such as Egypt, South Africa, Algeria, the UAE, and Saudi Arabia.

Obtain Premium Research Report Details, Considering the impact of COVID-19 @

Mortuary Equipment Industry News

In January 2018, HYGECO initiated a deal to sell mortuary equipment to the Blida and Tamanrasset military hospitals in Algeria.

In November 2017, Mopec Inc. announced a new cadaver lift offering versatility in design and performance.

Particle Counter Market: Growth Trends, Structure, Drivers, Scope And Challenges

Market Research Future recently published Particle Counter Market Research Report – Global Forecast till 2025, Concentrates On Restraints, Reimbursement Policies, Technological Advancements, competitive outlook

Particle Counter Market Scope

Global particle counter market size is expected to cross USD 168.2 Million by 2025 at a CAGR of 7.1% during the forecast period of 2019 to 2025.

Production of drugs, vaccines, and other chemicals by chemicals, pharmaceuticals, and other industries can drive the need for particle counters. Strict regulations pertaining to the removal of contaminants and removal of harmful bacteria can push the market demand greatly. Investments in research and development activities can fuel market demand as well. According to the National Institute for Health Research, the Association of the British Pharmaceutical Industry (ABPI) had invested close to USD 4.46 billion in 2015.

But high costs of particle counters can limit market growth.

Read more news on:

Particle Counter Market Competition

key players of the global particle counter market are –

  • Climet Instruments Company
  • Lighthouse Worldwide Solutions Inc.
  • Setra Systems
  • TSI Incorporated
  • Met One Instruments Inc.
  • Chemtrac Inc.
  • Particle Measuring Systems Inc.
  • Rion Co. Ltd.
  • Beckman Coulter 

Particle Counter Market Segmentation

The global particle counter market is segmented by product type, modularity, technology, and end user.

By product type, it is divided into liquid and airborne particle counters. Airborne particle counters are expected to take the lead in the market till 2025. This can be attributed to its sensitivity towards dust particles and ability to monitor room contamination. On the other hand, liquid particle counters can capture a significant market share owing to application in automotive, heavy machinery, and aviation & space exploration.

By modularity, it is segmented into handheld, portable, and remote particle counters.

By technology, it is divided into offline and online particle counters. Online particle counters can hold maximum market share owing to its ability to detect particles in lubricating and hydraulic systems.

By end user, it is segmented into pharmaceutical industry, medical device industry, research laboratories, and others.

Particle Counter Market Regional Analysis

Europe, the Americas, Asia Pacific (APAC), and the Middle East & Africa (MEA) are prime regions considered in the global particle counter market.

The Americas held the largest market share in 2018. It is likely to dominate the market during the forecast period owing to adoption of particle counters and regulations enforced by federal agencies. Launch of new products by players and expansion of product portfolios can encourage market growth.

Europe is expected to induce heavy demand for the global market due to the need for particle counters in medical device and pharmaceutical industries. The large population, a spike in healthcare spending, and support from governments are primary drivers of the regional market.

APAC accounted for the third position in the market due to investments by American and European stalwarts, developments in healthcare manufacturers, large number of research organizations, low manufacturing costs, and economical labor costs.

The MEA region accounted for the lowest market share due to limited investments in modernization of healthcare infrastructure.

Obtain Premium Research Report Details, Considering the impact of COVID-19 @

Create your website at
Get started